Saudi Arabia
· Delayed Price · Currency is SAR Middle East Healthcare Company Statistics
Total Valuation
Middle East Healthcare Company has a market cap or net worth of SAR 6.62 billion. The enterprise value is 9.13 billion.
| Market Cap | 6.62B |
| Enterprise Value | 9.13B |
Important Dates
The next estimated earnings date is Monday, November 4, 2024.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Middle East Healthcare Company has 92.04 million shares outstanding.
| Shares Outstanding | 92.04M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 4.84% |
| Float | 40.81M |
Valuation Ratios
The trailing PE ratio is 32.61 and the forward PE ratio is 24.27. Middle East Healthcare Company's PEG ratio is 0.86.
| PE Ratio | 32.61 |
| Forward PE | 24.27 |
| PS Ratio | 2.37 |
| PB Ratio | 4.04 |
| P/FCF Ratio | n/a |
| PEG Ratio | 0.86 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.80, with an EV/FCF ratio of -441.84.
| EV / Earnings | 45.01 |
| EV / Sales | 3.27 |
| EV / EBITDA | 14.80 |
| EV / EBIT | 21.73 |
| EV / FCF | -441.84 |
Financial Position
The company has a current ratio of 2.16, with a Debt / Equity ratio of 151.25.
| Current Ratio | 2.16 |
| Quick Ratio | 1.95 |
| Debt / Equity | 151.25 |
| Debt / EBITDA | 4.12 |
| Debt / FCF | -123.03 |
| Interest Coverage | 1.81 |
Financial Efficiency
Return on equity (ROE) is 12.68% and return on invested capital (ROIC) is 6.53%.
| Return on Equity (ROE) | 12.68% |
| Return on Assets (ROA) | 5.21% |
| Return on Capital (ROIC) | 6.53% |
| Revenue Per Employee | 661,783 |
| Profits Per Employee | 48,085 |
| Employee Count | 4,220 |
| Asset Turnover | 0.55 |
| Inventory Turnover | 17.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.78% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +24.78% |
| 50-Day Moving Average | 77.41 |
| 200-Day Moving Average | 90.51 |
| Relative Strength Index (RSI) | 43.14 |
| Average Volume (20 Days) | 351,485 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Middle East Healthcare Company had revenue of SAR 2.79 billion and earned 202.92 million in profits. Earnings per share was 2.20.
| Revenue | 2.79B |
| Gross Profit | 1.09B |
| Operating Income | 420.37M |
| Pretax Income | 224.95M |
| Net Income | 202.92M |
| EBITDA | 601.58M |
| EBIT | 420.37M |
| Earnings Per Share (EPS) | 2.20 |
Balance Sheet
The company has 72.31 million in cash and 2.54 billion in debt, giving a net cash position of -2.47 billion or -26.84 per share.
| Cash & Cash Equivalents | 72.31M |
| Total Debt | 2.54B |
| Net Cash | -2.47B |
| Net Cash Per Share | -26.84 |
| Equity (Book Value) | 1.68B |
| Book Value Per Share | 17.78 |
| Working Capital | 1.39B |
Cash Flow
In the last 12 months, operating cash flow was 196.01 million and capital expenditures -216.68 million, giving a free cash flow of -20.67 million.
| Operating Cash Flow | 196.01M |
| Capital Expenditures | -216.68M |
| Free Cash Flow | -20.67M |
| FCF Per Share | -0.22 |
Margins
Gross margin is 38.98%, with operating and profit margins of 15.05% and 7.10%.
| Gross Margin | 38.98% |
| Operating Margin | 15.05% |
| Pretax Margin | 8.06% |
| Profit Margin | 7.10% |
| EBITDA Margin | 21.54% |
| EBIT Margin | 15.05% |
| FCF Margin | -0.74% |
Dividends & Yields
Middle East Healthcare Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 3.07% |
| FCF Yield | -0.31% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |